UK markets closed

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4500-0.0300 (-2.03%)
At close: 04:00PM EDT
1.4000 -0.05 (-3.45%)
After hours: 07:30PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
29,643
38,120
29,997
20,337
14,904
Selling general and administrative
12,125
12,243
11,658
10,927
12,908
Total operating expenses
41,768
50,363
41,655
31,264
27,812
Operating income or loss
-41,768
-50,363
-41,655
-31,264
-27,812
Interest expense
39
-
0
370
908
Total other income/expenses net
112
-
70
-50,576
-836
Income before tax
-40,625
-42,494
-39,225
-82,181
-29,468
Income tax expense
-13
0
0
0
32
Income from continuing operations
-40,612
-42,494
-39,225
-82,181
-29,500
Net income
-40,612
-42,494
-39,225
-82,181
-29,500
Net income available to common shareholders
-40,612
-42,494
-39,225
-82,181
-29,500
Basic EPS
-0.33
-
-0.37
-1.31
-0.96
Diluted EPS
-0.33
-
-0.37
-1.31
-0.96
Basic average shares
124,610
-
105,186
62,870
30,776
Diluted average shares
124,610
-
105,186
62,870
30,776